Nina Capital’s Post

THE IMPORTANCE OF DWIBS (Diffusion-Weighted Imaging with Background Suppression) IN WHOLE BODY MRI Early detection is critical for proactive health screening, and DWIBS plays a vital role in this process. As part of the Whole Body MRI, DWIBS uncovers microscopic tissue changes that traditional imaging methods may miss, enhancing early detection and diagnostic accuracy. What is DWIBS? DWIBS is a specialised MRI technique that measures the movement of water molecules in tissues, with background suppression to improve image clarity. In healthy tissues, water molecules move freely, while in abnormal tissues—such as those affected by tumours or inflammation—movement is restricted. DWIBS detects these changes, making it an essential tool for identifying early-stage cancers and other abnormalities. Why DWIBS is Crucial for Whole Body MRI Early Cancer Detection DWIBS is particularly effective at detecting small tumours, often before symptoms appear. It can identify cancers in organs like the brain, liver, prostate, and more—helping to catch them early when they’re more treatable. Enhanced Sensitivity DWIBS improves the sensitivity of Whole Body MRI, providing more detailed and clearer images of internal structures. This helps to detect subtle changes in tissues that may indicate diseases such as cancer, infections, or other conditions. Non-invasive and Precise DWIBS is a non-invasive method, meaning it doesn’t require surgery or biopsies to gather critical information about your body’s health. This precision allows for earlier detection and faster intervention with minimal patient discomfort. Improved Detection of Metastasis DWIBS is invaluable for detecting metastasis, helping identify whether cancer has spread to lymph nodes or distant organs. By spotting these signs early, DWIBS allows for quicker treatment and better patient outcomes. A Key Part of Comprehensive Screening DWIBS is an essential component of Whole Body MRI because it provides more than just anatomical images; it also offers insights into tissue behavior and abnormalities. This creates a more complete picture of your health, ensuring nothing is missed during the screening. At Mermaid Beach Radiology, we offer the most comprehensive Whole Body MRI available, incorporating DWIBS to uncover abnormalities that others may miss. With DWIBS, we offer unmatched precision in early detection—making it a key feature of our Whole Body MRI. Without DWIBS, it’s not truly a Whole Body MRI. Zane Sherif Ben Kennedy Amanda Forbes Winspear

"Many radiologists say the likelihood of finding a serious problem, such as a cancerous tumor or brain aneurysm, in someone with no symptoms is very low. Instead, scans are likely to flag growths that are usually harmless. Definitively ruling out a problem could require additional tests, appointments and even surgeries." https://lnkd.in/edU2nHNs #earlydetection #cancer #disease #aneurysms #health #patients #americans #mri #imaging #consumers #imagingcenters #radiology #cancerprevention

With continuous declines in physician payments, every detail counts. Check out our latest blog on Interventional Pain Management documentation tips to prevent denials and improve payments. https://bit.ly/3wRbf6R #interventionalpainmanagement #radiology #RCM #streamlinemd

Way to step up, Mississippi! Patients in MS will no longer incur out of pocket expenses for supplemental and diagnostic breast imaging!! We are often at or near the bottom of many health-related rankings, so this is a great step forward. If MS can do it, every state can do it. Thank you, MS legislators!! #breastcancer #densebreast #diagnosticimaging #radiology #womenshealth #mammography

Worried about expensive cancer treatment? 60-70% of people have insurance coverage of under 5 lakh rupees. With the cancer cost being more than 10 lakh rupees in most of the cases, it is very important to plan the treatment very meticulously so that you can decrease your out of pocket expense. What can you do to cover your maximum journey in the insurance? 1. Get a complete idea of your treatment journey. Ask your doctors how long will the treatment go on for. What will the different treatment modalities involved, i.e Chemotherapy, targeted therapy, surgery, immunotherapy, radiation etc. 2. If you see that your coverage is less than your overall cost then ask your consulting doctors what are the ways in which you can optimise each of these cost. 3. You can reduce your chemotherapy cost by getting it done in a day care chemotherapy centre as the cost of chemotherapy centre at a day care centre is generally on a lower side. 4. You can look for hospitals which have a lower cost of the same treatment under insurance. 5. Diagnostics done pre and post admissions are covered under insurance, so remember to keep all your bills and file for reimbursement after you get discharged from hospital. #oncarecares #cancerawareness #cancertreatment #cancersupport #healthcare #trending

MRI Systems Market Worth $6.6 billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬:https://bit.ly/4dRKJe9 The global MRI systems market in terms of revenue was estimated to be worth $5.2 billion in 2023 and is poised to reach $6.6 billion by 2028, growing at a CAGR of 5.0% from 2023 to 2028. 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜: Japan is expected to dominate the market, with China seeing growth due to government initiatives and an aging population. India faces challenges due to healthcare policy uncertainties. 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚: The US is highlighted as a major market due to the rising incidence of chronic diseases. Canada also shows potential with increasing incidences of heart and kidney diseases. 𝐄𝐮𝐫𝐨𝐩𝐞: Germany and the UK are seeing growth due to investments in diagnostic imaging centers. France and Italy are driven by government investments and a strong healthcare infrastructure. 𝐋𝐚𝐭𝐢𝐧 𝐀𝐦𝐞𝐫𝐢𝐜𝐚: Brazil and Mexico are leading markets, with Brazil's market growth driven by an increasing disease burden and healthcare insurance adoption. 𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 & 𝐀𝐟𝐫𝐢𝐜𝐚: The market is expected to grow due to increasing investments by key players, with specific focus on field strength and architecture of MRI systems. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Siemens Healthineers (Germany), GE Healthcare (US), and Koninklijke Philips N.V. (Netherlands). 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Mediso Medical Imaging Systems  Eyas Medical Imaging Universal Medical Inc Multiwave Technologies AG  Naslund Medical Purpleblue Medical Ltd   Anaecon India Healthcare Pvt. Ltd   Rothband (WSR Medical Solutions Ltd)      Digital X-Ray Technologies Bay Shore Medical Equipment, LLC  United Imaging Systems TechnoRad CogSmart Asia Limited | 株式会社CogSmart      C37 HEALTHCARE PRIVATE LIMITED Prizmed Imaging Solutions, Inc.     MEDNOB HEALTHCARE Canon Medical Systems Korea Co., Ltd.  CSP Medical Alpha Biomedical & Diagnostic, Corp. ViewRay Systems, Inc. Meditec Systems Ltd Allex Medical Systems GEOID Medical Systems Roxon medi-tech ltd IMOTEK INTERNATIONAL LIMITED Kosmed Sp. z o. o. IASIS Air-Eze Scientific Services Medimax-RSI Rx Medical Systems & Services  Mansa Medical Al-Aziz Importex Global OPx Soluções Inteligentes    IMEDCO America LifeMed Oy iRad Sales Group, LLC Melorin Arvin Teb   Nanjing Fullshare Superconducting Technology Co., Ltd.      CARE MENTOR AI Intermed Oy | Service |

Can you recommend the best soft tissue sarcoma treatment doctors in panipat? #drsurenderdabas.com #sarcoma #sarcomatreatment #softtissue #sarcomainpanipat #softtissuetherapy Description: Dr. Surender Dabas stands as a paragon of medical excellence, specializing in soft tissue sarcoma treatment. With a wealth of experience and a reputation for delivering outstanding patient care, Dr. Dabas has emerged as the go-to expert in Panipat for those seeking top-tier medical intervention. Why Choose Dr. Surender Dabas: Expertise: Dr. Dabas boasts a proven track record in successfully treating soft tissue sarcoma cases, showcasing unparalleled expertise in the field. Cutting-edge Technology: The clinic employs state-of-the-art technology, ensuring that patients receive the most advanced and effective treatment options available. Comprehensive Care: Beyond medical expertise, Dr. Dabas and his team prioritize holistic patient care, providing emotional support and guidance throughout the treatment journey. Patient-Centric Approach: Every patient is unique, and Dr. Surender Dabas tailors treatment plans to individual needs, fostering a patient-centric approach that prioritizes optimal outcomes. Frequently Asked Questions about soft tissue sarcoma treatment Q1: What sets Dr. Surender Dabas apart from other soft tissue sarcoma treatment providers in Panipat? A: Dr. Dabas brings a combination of extensive experience, cutting-edge technology, and a patient-centric approach, making him a standout choice for best soft tissue sarcoma treatment doctors in panipat. Q2: How can I schedule a consultation with Dr. Surender Dabas? A: Booking a consultation is convenient. You can either call our clinic directly or visit our website to request an appointment. Our team will guide you through the process seamlessly. Q3: What treatment options does Dr. Dabas offer for soft tissue sarcoma? A: Dr. Surender Dabas provides a range of treatment options tailored to each patient’s unique needs. These may include surgery, radiation therapy, chemotherapy, and targeted therapies, among others. Q4: How long does a typical soft tissue sarcoma treatment plan last? A: The duration of treatment varies based on individual cases. Dr. Dabas will discuss the proposed treatment plan and expected timeline during your consultation. Q5: Does Dr. Surender Dabas accept insurance for soft tissue sarcoma treatment? A: Yes, our clinic works with various insurance providers. We recommend checking with our administrative staff during the appointment scheduling process to ensure a smooth insurance-related experience.

US$21 Mln Funding The pain in your back is too much to bear. Or, perhaps you fear arthritis is setting in. Whatever the cause, your physician recommended you get an MRI to have the problem examined. The only problem is that you just found out that your local hospital charges more than you can afford. A family took their 3 years old daughter for an MRI. She suffered from a rare genetic disorder and had already undergone CT scans, colonoscopies, ultrasounds and other tests. Based on those experiences, the family assumed the MRI cost would be a few thousand dollars. So, they opted for an out-of-network provider in their area and agreed to pay half of the cost themselves. Then they got the bill. They owed well over $25,000. NICHE TO MAINSTREAM A traditional or closed MRI scan is expensive. And an MRI scan with contrast also costs more. It can be as much as several thousand dollars without any insurance at all. Although there are several factors affecting the cost you will have to pay for an MRI. The prices can vary based on the body part scanned, your health insurance, and the place of service, In-network vs. out-of-network providers, places of service, region or country, sedatives, radiologist reading etc. Overhead costs can help explain why hospitals charge so much for MRIs. The hospital must buy the MRI equipment and then pay to keep it maintained and updated. Additionally, the MRI administrator charges fees to the hospital. Tackling the challenge has created a massive market opportunity for startups offering solutions to patients. One of the startups leveraging AI technology to reduce the cost of MRI scan for early cancer detection is Ezra. Ezra is a healthcare Artificial Intelligence (AI) company transforming MRI imaging and early cancer detection. Ezra leverages FDA-cleared AI technology to reduce the time it takes to complete an MRI scan. Ezra stands apart by leveraging proprietary AIs across all three key components of the cancer screening process: imaging, analysis, and reporting. These three AI innovations have enabled Ezra to reduce the price of an Ezra Full Body MRI scan by 40%, making the Ezra Full Body Flash one of the most affordable full body MRI scans on the market. By deploying its AIs at leading imaging centers, Ezra offers consumers the ability to access full-body MRI scanning at much more affordable pricing, and supports imaging centers in increasing throughput, efficiency, and affordability. Founded in 2018 by Emi Gal, Ezra has raised $21 million in funding. The investment will be used to accelerate the company’s expansion in 2024, as well as advance the use of its AI technology by leading imaging centers and clinicians. #funding #healthcare #startup #vcdeal

💸𝘾𝙤𝙣𝙜𝙧𝙖𝙩𝙪𝙡𝙖𝙩𝙞𝙤𝙣𝙨 to Mainstay Medical who Announces $𝟭𝟮𝟱 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 Equity Financing Transaction!!! The funds will be used to support the company’s continued commercial growth of ReActiv8® Restorative Neurostimulation in the U.S., Europe and Australia, additional post-market clinical studies, research, and general operations. 🗣️CEO, Jason Hannon commented; “𝘞𝘦 𝘢𝘳𝘦 𝘯𝘰𝘸 𝘴𝘵𝘳𝘰𝘯𝘨𝘭𝘺 𝘤𝘢𝘱𝘪𝘵𝘢𝘭𝘪𝘻𝘦𝘥 𝘵𝘰 𝘦𝘹𝘦𝘤𝘶𝘵𝘦 𝘰𝘯 𝘰𝘶𝘳 𝘤𝘰𝘳𝘱𝘰𝘳𝘢𝘵𝘦 𝘰𝘣𝘫𝘦𝘤𝘵𝘪𝘷𝘦𝘴. 𝘐𝘯 𝘢𝘥𝘥𝘪𝘵𝘪𝘰𝘯 𝘵𝘰 𝘤𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭 𝘦𝘹𝘱𝘢𝘯𝘴𝘪𝘰𝘯 𝘪𝘯 𝘰𝘶𝘳 𝘵𝘢𝘳𝘨𝘦𝘵 𝘮𝘢𝘳𝘬𝘦𝘵𝘴, 𝘵𝘩𝘦𝘴𝘦 𝘰𝘣𝘫𝘦𝘤𝘵𝘪𝘷𝘦𝘴 𝘪𝘯𝘤𝘭𝘶𝘥𝘦 𝘵𝘩𝘦 𝘨𝘦𝘯𝘦𝘳𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘢𝘥𝘥𝘪𝘵𝘪𝘰𝘯𝘢𝘭 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘩𝘦𝘢𝘭𝘵𝘩 𝘦𝘤𝘰𝘯𝘰𝘮𝘪𝘤 𝘥𝘢𝘵𝘢 𝘵𝘰 𝘧𝘶𝘳𝘵𝘩𝘦𝘳 𝘥𝘦𝘮𝘰𝘯𝘴𝘵𝘳𝘢𝘵𝘦 𝘵𝘩𝘢𝘵 𝘙𝘦𝘈𝘤𝘵𝘪𝘷8’𝘴 𝘱𝘶𝘳𝘱𝘰𝘴𝘦-𝘣𝘶𝘪𝘭𝘵, 𝘳𝘦𝘴𝘵𝘰𝘳𝘢𝘵𝘪𝘷𝘦 𝘢𝘱𝘱𝘳𝘰𝘢𝘤𝘩 𝘵𝘰 𝘵𝘩𝘦 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘰𝘧 𝘮𝘦𝘤𝘩𝘢𝘯𝘪𝘤𝘢𝘭 𝘤𝘩𝘳𝘰𝘯𝘪𝘤 𝘭𝘰𝘸 𝘣𝘢𝘤𝘬 𝘱𝘢𝘪𝘯 𝘪𝘴 𝘴𝘶𝘱𝘦𝘳𝘪𝘰𝘳 𝘵𝘰 𝘤𝘰𝘮𝘱𝘦𝘵𝘪𝘵𝘪𝘷𝘦 𝘵𝘩𝘦𝘳𝘢𝘱𝘪𝘦𝘴 𝘰𝘳𝘪𝘨𝘪𝘯𝘢𝘭𝘭𝘺 𝘥𝘦𝘴𝘪𝘨𝘯𝘦𝘥 𝘧𝘰𝘳 𝘰𝘵𝘩𝘦𝘳 𝘪𝘯𝘥𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴, 𝘢𝘴 𝘸𝘦𝘭𝘭 𝘢𝘴 𝘵𝘩𝘦 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘦𝘥 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘦𝘯𝘧𝘰𝘳𝘤𝘦𝘮𝘦𝘯𝘵 𝘰𝘧 𝘰𝘶𝘳 𝘥𝘰𝘮𝘪𝘯𝘢𝘯𝘵 𝘪𝘯𝘵𝘦𝘭𝘭𝘦𝘤𝘵𝘶𝘢𝘭 𝘱𝘳𝘰𝘱𝘦𝘳𝘵𝘺 𝘱𝘰𝘳𝘵𝘧𝘰𝘭𝘪𝘰.” So 𝙬𝙝𝙖𝙩 is their ReActiv8® Restorative Neurostimulation Technology? ⚡ReActiv8 is an implantable medical device designed to treat adults with intractable chronic low back pain (CLBP) associated with multifidus muscle dysfunction ⚡The therapy targets the multifidus muscle with electrical pulses and is implanted adjacent the medial branch of the dorsal ramus. Can't wait to see what more is to come from them in advancing CLBP! #neuromodulation #neurology #funding #neuroscience

I am excited to share our recent publication on patient factors associated with an early transition from hemodialysis (HD) to either kidney transplantation or peritoneal dialysis (PD) after autogenous arteriovenous (AV) access creation. After AV access creation for end-stage renal disease, most patients continue on HD; some receive kidney transplants, and a subset transition to PD. Our study aimed to identify patient factors linked to early transitions from HD to kidney transplantation or PD. Methods: This case-control study analyzed data from the Vascular Quality Initiative (2011–2022) focused on patients with first-time AV access creation and long-term follow-up. Control group patients remained on HD, while the case groups included patients who received early kidney transplants or converted to PD. Univariable analysis showed variation in transplantation and PD conversion rates with race, insurance status, area deprivation index (ADI) quintile, and medical comorbidities. Multivariable analysis linked impaired ambulation, current smoking, non-commercial insurance, Black race, heart failure, higher BMI, and older age to decreased transplantation rates. Conversion to PD was less likely with impaired ambulation, Hispanic ethnicity, Black race, former smoking, controlled diabetes, and older age, while higher ADI quintiles increased conversion rates. Black race and non-commercial insurance were associated with decreased kidney transplantation rates, highlighting disparities beyond community-level access to care. Early kidney transplantation offered a 3-year survival benefit over HD and PD, which had similar survival rates. Efforts are needed to improve access to kidney transplantation and PD. Quote: "It's a privilege to reflect on how I could learn and hopefully contribute to the field of vascular access over a decade, starting from one of my earliest clinical research projects during my general surgery residency." #arterio_venous_access #peritoneal_dialysis #health_disparities https://lnkd.in/ecvA64AC